Evidence map›Paper›PMID 29670672›Full record

ArticleDisease markers2018

Mitochondrial Genome Mutations Associated with Myocardial Infarction.

Margarita A Sazonova, Anastasia I Ryzhkova, Vasily V Sinyov, Elena V Galitsyna, Alexandra A Melnichenko, Natalya A Demakova, Igor A Sobenin, Tatiana P Shkurat, Alexander N Orekhov

Open access · hybridAbstract read
In one paragraph

Article in Disease markers, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. The Diseased Mitoribosome.FEBS letters · 2021
    Review
  12. Review
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Margarita A SazonovaLaboratory of Angiopathology, Institute of General Pathology and Pathophysiology, Moscow 125315, Russia.ORCID 0000-0002-8610-4593
Anastasia I RyzhkovaLaboratory of Angiopathology, Institute of General Pathology and Pathophysiology, Moscow 125315, Russia.
Vasily V SinyovLaboratory of Medical Genetics, National Medical Research Center of Cardiology, Moscow 121552, Russia.ORCID 0000-0001-5105-5763
Elena V GalitsynaDepartment of Genetics, Southern Federal University, Rostov-on-Don 344006, Russia.
Alexandra A MelnichenkoLaboratory of Medical Genetics, National Medical Research Center of Cardiology, Moscow 121552, Russia.
Natalya A DemakovaDepartment of Genetics, Southern Federal University, Rostov-on-Don 344006, Russia.
Igor A SobeninLaboratory of Angiopathology, Institute of General Pathology and Pathophysiology, Moscow 125315, Russia.ORCID 0000-0003-0978-6444
Tatiana P ShkuratDepartment of Genetics, Southern Federal University, Rostov-on-Don 344006, Russia.
Alexander N OrekhovLaboratory of Angiopathology, Institute of General Pathology and Pathophysiology, Moscow 125315, Russia.ORCID 0000-0002-6495-1628
Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences · RUSouthern Federal University · RUNational Medical Research Center of Cardiology · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myocardial infarction is one of the clinical manifestations of coronary heart disease. In some cases, the cause of myocardial infarction may be atherosclerotic plaques which occurred in the human aorta. The association of mtDNA mutations with atherosclerotic lesions in human arteries was previously detected by our research group. In this study, we used samples of white blood cells collected from 225 patients with myocardial infarction and 239 control persons with no health complaints. DNA was isolated from the blood leukocyte samples. Then, PCR fragments of DNA were obtained. They contained the investigated regions of 11 mitochondrial genome mutations (m.5178C>A, m.3336T>C, m.652delG, m.12315G>A, m.14459G>A, m.652insG, m.14846G>A, m.13513G>A, m.1555A>G, m.15059G>A, m.3256C>T). According to the obtained results, three mutations of the human mitochondrial genome correlated with myocardial infarction. A positive correlation was observed for mutation m.5178C>A. At the same time, a highly significant negative correlation with myocardial infarction was observed for mutation m.14846G>A. One single-nucleotide substitution of m.12315G>A had a trend towards negative correlation. These mutations can potentially be useful for creating molecular/cellular models for studying the mechanisms of myocardial infarction and designing novel therapies. Moreover, these mutations can possibly be used for diagnostic purposes.

Indexed as

Genome, MitochondrialMutationAdultAgedAged, 80 and overCase-Control StudiesFemaleHumansMaleMiddle AgedMyocardial Infarction

Identifiers

PMID29670672
PMCPMC5835263
OpenAlexW2792429760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.